| Market Cap | €2.42B | |
| Enterprise Value | €2.42B | |
| Revenue | €1.74B | +1.2% |
| Gross Profit | €455.7M | +0.7% |
| EBITDA | €276.9M | +15.3% |
| Net Income | €163.3M | +27.7% |
| Diluted EPS | €2.54 | +27.6% |
| Free Cash Flow | €143.0M | +5.4% |
| DPS (FY2025) | — |
| Trailing yield | — |
| Payout ratio | 39.3% |
| Growth streak | — |
| 5y DPS growth | — |
| Fiscal year | DPS | YoY | Basis |
|---|---|---|---|
| FY20252025-12-31 | — | — | reported |
| FY20232023-12-31 | — | — | reported |
| Ratio | 2023 | 2024 | 2025 | Trend · 3y | vs own |
|---|---|---|---|---|---|
| ▾Margins | |||||
| Gross Margin | 24.85% | 26.30% | 26.17% | 50% | |
| Operating Margin | 11.72% | 10.14% | 12.66% | 83% | |
| EBITDA Margin | 14.51% | 13.96% | 15.90% | 83% | |
| NOPAT Margin | 9.40% | 7.52% | 9.79% | 83% | |
| Net Margin | 9.46% | 7.43% | 9.38% | 50% | |
| FCF Margin | 8.07% | 7.89% | 8.21% | 83% | |
| FCFF Margin | 8.62% | 8.71% | 8.95% | 83% | |
| FCFE Margin | 10.51% | 4.99% | 5.36% | 50% | |
| OCF Margin | 10.80% | 10.24% | 12.02% | 83% | |
| Gross Profitability | 27.59% | 26.68% | 26.06% | 17% | |
| Capex Intensity | 2.73% | 2.35% | 3.81% | 83% | |
| ▸Returns on Capital · 6 ratios | |||||
| ▸DuPont factors (ROE drivers) · 4 ratios | |||||
| ▸Earnings quality · 7 ratios | |||||
| ▸Liquidity & coverage · 9 ratios | |||||
| ▸Leverage · 7 ratios | |||||
| ▸Working capital · 8 ratios | |||||
| ▸Capital allocation · 5 ratios | |||||
| ▸Other · 1 ratios | |||||
The five drivers multiply to 23.1% vs reported ROE 24.1%. High ROE from margin and turnover is earned; from the equity multiplier it is borrowed.
| Line | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | €2.05B | €1.72B | €1.74B |
| YoY % | -16.1% | +1.2% | |
| Cost of Revenue | €1.54B | €1.27B | €1.29B |
| YoY % | -17.7% | +1.4% | |
| Gross Profit | €509.3M | €452.5M | €455.7M |
| YoY % | -11.2% | +0.7% | |
| R&D Expense | €54.3M | €54.0M | €53.8M |
| YoY % | -0.6% | -0.4% | |
| Selling & Marketing Expense | €85.1M | €88.1M | €91.9M |
| YoY % | +3.5% | +4.3% | |
| SG&A Expense | €130.4M | €110.0M | €93.5M |
| YoY % | -15.6% | -15.0% | |
| Operating Income | €240.2M | €174.4M | €220.4M |
| YoY % | -27.4% | +26.4% | |
| Interest Expense | €14.0M | €19.0M | €16.7M |
| YoY % | +35.7% | -12.1% | |
| Interest & Investment Income | €15.3M | €17.0M | €7.4M |
| YoY % | +11.1% | -56.5% | |
| Equity Method Income | €9.0M | €4.6M | -€3.1M |
| YoY % | -48.9% | ||
| Pretax Income | €241.5M | €172.5M | €211.2M |
| YoY % | -28.6% | +22.4% | |
| Income Tax | €47.7M | €44.6M | €47.8M |
| YoY % | -6.5% | +7.2% | |
| Net Income (incl. NCI) | €193.8M | €127.9M | €163.3M |
| YoY % | -34.0% | +27.7% | |
| Minority Interest (P&L) | €0 | €0 | €0 |
| Net Income | €193.8M | €127.9M | €163.3M |
| YoY % | -34.0% | +27.7% | |
| EPS (Basic) | €3.01 | €1.99 | €2.55 |
| YoY % | -33.9% | +28.1% | |
| EPS (Diluted) | €3.01 | €1.99 | €2.54 |
| YoY % | -33.9% | +27.6% |
Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
